In addition, transnasal administration of oxytocin has been used in randomized controlled trials in various neuropsychiatric disorders, such as Autism Spectrum Disorder, Generalized/Social Anxiety Disorder, and Posttraumatic Stress Disorder; some of these studies are listed in Table 1. This evidence concerns the gene OXT and post-traumatic stress disorder.